This crisis has united multidisciplinary groups and laid the foundation to better equip the health care workforce for future pandemics.
A preview of our August 2021 issue Chairman’s Letter.
This novel therapeutic option represents the first long-acting injectable approved for maintenance of HIV-1 suppression.
Both undertreatment and overtreatment were common in this cohort of penicillin-allergic pregnant women with Group B Streptococcus (GBS).
Gender-affirming hormone therapy (GAHT) therapy consists of administration of exogenous hormones and suppression of endogenous hormone production, with the goal of obtaining characteristics more congruent with an individual’s gender identity. Here is a review of these therapies and consideration for PrEP and the risks associated with HIV in this diverse population.
This form of stewardship can reduce unnecessary antibiotic prescribing, reduce costs, and optimize patient outcomes.
The need for safe and effective treatment against the various strains of COVID-19 increase, and investigators continue to assess various pharmacologic options.
Hospitals grapple with the costly burden of healthcare-associated infections (HAIs), and artificial intelligence (AI) is emerging as a game-changer in revolutionizing infection prevention strategies.
Changes in microbiology and antimicrobial resistance patterns warrant reevaluation of our current therapies for this condition.
Clinical and public health laboratories reported increased influenza virus detections over the past few weeks, but US cases remains comparatively low to previous flu seasons.
This study characterized the incidence of serotonin syndrome and identified contributing risk factors with combined medications for opioid use disorder (MOUD) and linezolid use.
Important clinical considerations to know about resistant CMV infections.
The limitation in the number of pediatric-specific guidelines by professional organizations, and results from large randomized clinical trials, may place an additional emphasis on literature evaluation skills for pediatric ASP pharmacists.
By addressing ART-related medication errors and increasing linkage to care, antiretroviral stewardship programs can improve management of inpatients with HIV.
Expanding the differential for diarrhea beyond Clostridium difficile.
A research team from the Netherlands turns to deep sequencing technology to detect hepatitis C virus resistant variants.
A quick debrief of the week’s top FDA approvals, FDA authorizations, or other infectious disease pipeline developments from the past week.
Biofilms are an emerging clinical problem despite the fact that most clinicians don’t even think of biofilms when managing infections.
Men who have sex with men who seek out sexual partners online are more likely to report sexually transmitted infections, including syphilis, gonorrhea, and chlamydia.
The globalization of antibiotic stewardship programs is necessary in the fight against antibiotic resis­tance.
With IV drug use accounting for 60% of new infections, treatment for individuals in this population is necessary to stave off new infections.
This In the Literature piece explores if we can mitigate some of the adverse reactions that are being seen in obese patients who receive vancomycin through AUC-dosing.
Infections transmitted by these bloodsucking species are on the rise worldwide.
Amesh A. Adalja, MD, FIDSA argues that a bill being considered in the Pennsylvania state legislature will ultimately result in increased antibiotic resistance and will set back the clock for finding appropriate treatments for Lyme disease.